Narrative Update • Jun 26
Have your own idea? Try our Stock Screener
U.K. (FTSE) Clinical Research and Equipment Industry Analysis
UpdatedJul 04, 2026
DataAggregated Company Financials
Companies7
- 7D-2.4%
- 3M-0.001%
- 1Y-16.3%
- YTDn/a
The Clinical Research and Equipment industry is up 1.4% in the last week, with hVIVO up 3.6%. In the past year, the industry is down 14%. As for the next few years, earnings are expected to grow by 57% per annum.
Industry Valuation and Performance
Has the U.K. Clinical Research and Equipment Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Sat, 04 Jul 2026 | UK£1.4b | UK£323.1m | -UK£164,731,254.00 | 1274.4x | -8.4x | 4.3x |
| Mon, 01 Jun 2026 | UK£1.6b | UK£323.0m | -UK£166,018,254.00 | 1248.2x | -9.7x | 5x |
| Wed, 29 Apr 2026 | UK£1.3b | UK£318.2m | -UK£167,469,254.00 | n/a | -7.9x | 4.2x |
| Fri, 27 Mar 2026 | UK£1.4b | UK£324.0m | -UK£161,423,254.00 | 8.6x | -8.4x | 4.2x |
| Sun, 22 Feb 2026 | UK£1.6b | UK£304.7m | -UK£159,511,254.00 | 12.1x | -9.8x | 5.1x |
| Tue, 20 Jan 2026 | UK£1.7b | UK£304.6m | -UK£159,441,254.00 | 7.3x | -10.5x | 5.5x |
| Thu, 18 Dec 2025 | UK£1.4b | UK£304.6m | -UK£159,441,254.00 | 8.4x | -8.8x | 4.6x |
| Sat, 15 Nov 2025 | UK£1.5b | UK£304.3m | -UK£163,156,254.00 | 8.2x | -9.1x | 4.9x |
| Mon, 13 Oct 2025 | UK£1.6b | UK£304.3m | -UK£163,156,254.00 | 8.9x | -10x | 5.4x |
| Wed, 10 Sep 2025 | UK£1.9b | UK£313.5m | -UK£158,190,352.00 | 6.3x | -11.8x | 5.9x |
| Fri, 08 Aug 2025 | UK£2.3b | UK£291.9m | -UK£160,968,352.00 | 6.5x | -14.1x | 7.8x |
| Sun, 06 Jul 2025 | UK£1.6b | UK£291.9m | -UK£160,968,352.00 | 6.9x | -10.1x | 5.6x |
| Tue, 03 Jun 2025 | UK£1.6b | UK£319.4m | -UK£190,791,730.00 | 6.8x | -8.2x | 4.9x |
| Thu, 01 May 2025 | UK£1.6b | UK£313.8m | -UK£192,342,507.95 | 12.2x | -8.5x | 5.2x |
| Sat, 29 Mar 2025 | UK£1.5b | UK£315.7m | -UK£186,460,928.95 | 5.5x | -7.9x | 4.7x |
| Mon, 24 Feb 2025 | UK£1.7b | UK£306.4m | -UK£195,137,615.28 | 6.9x | -8.9x | 5.7x |
| Wed, 22 Jan 2025 | UK£2.2b | UK£307.3m | -UK£195,826,248.00 | 7.4x | -11.2x | 7.1x |
| Fri, 20 Dec 2024 | UK£1.9b | UK£306.7m | -UK£195,368,827.20 | 7.7x | -9.9x | 6.3x |
| Sun, 17 Nov 2024 | UK£1.8b | UK£305.8m | -UK£193,578,219.28 | 10.2x | -9.5x | 6x |
| Tue, 15 Oct 2024 | UK£2.0b | UK£304.4m | -UK£192,350,536.90 | 10.6x | -10.4x | 6.6x |
| Thu, 12 Sep 2024 | UK£2.0b | UK£302.2m | -UK£191,172,312.20 | 11.5x | -10.3x | 6.5x |
| Sat, 10 Aug 2024 | UK£1.8b | UK£296.8m | -UK£189,164,393.70 | 12.3x | -9.6x | 6.1x |
| Mon, 08 Jul 2024 | UK£1.6b | UK£295.5m | -UK£189,930,390.09 | 11.7x | -8.2x | 5.3x |
| Wed, 05 Jun 2024 | UK£1.6b | UK£295.5m | -UK£189,747,852.33 | 11.4x | -8.4x | 5.4x |
| Fri, 03 May 2024 | UK£1.5b | UK£292.8m | -UK£188,926,296.41 | 7008.4x | -8.1x | 5.2x |
| Sun, 31 Mar 2024 | UK£1.7b | UK£319.1m | -UK£191,403,096.81 | 69.8x | -9.1x | 5.5x |
| Tue, 27 Feb 2024 | UK£1.9b | UK£285.8m | -UK£189,173,841.82 | 6858.1x | -10.1x | 6.7x |
| Thu, 25 Jan 2024 | UK£2.8b | UK£450.2m | -UK£176,556,056.00 | 62.5x | -15.7x | 6.1x |
| Sat, 23 Dec 2023 | UK£3.1b | UK£450.0m | -UK£174,026,893.00 | 52.7x | -18.1x | 7x |
| Mon, 20 Nov 2023 | UK£3.1b | UK£455.8m | -UK£168,862,697.00 | 50.3x | -18.1x | 6.7x |
| Wed, 18 Oct 2023 | UK£2.9b | UK£458.6m | -UK£165,563,414.00 | 50x | -17.3x | 6.2x |
| Fri, 15 Sep 2023 | UK£3.1b | UK£440.6m | -UK£167,086,339.00 | 67.5x | -18.6x | 7.1x |
| Sun, 13 Aug 2023 | UK£3.3b | UK£476.2m | -UK£126,558,560.00 | 70.6x | -25.8x | 6.8x |
| Tue, 11 Jul 2023 | UK£2.9b | UK£476.3m | -UK£124,530,866.00 | 66.1x | -23.4x | 6.1x |
Price to Earnings Ratio
-23.4x
Current Industry PE
- Investors are pessimistic on the British Life Sciences Tools and Services industry, indicating that they anticipate long term growth rates will be lower than they have historically.
- The 3-year average PS ratio of 5.8x is higher than the industry's current PS ratio of 4.4x.
Past Earnings Growth
- The earnings for companies in the Life Sciences Tools and Services industry have deteriorated over the last three years.
- Revenues have also declined 12% per year.
- This means overall sales from these companies are declining and losses are subsequently expanding as well.
Industry Comparison
How does U.K. Clinical Research and Equipment compare with similar industries?
| GB Market | 1.61% | |
| Healthcare | 1.40% | |
| Life Sciences | -2.42% | |
| Clinical Research and Equipment | -2.42% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| HVO hVIVO | UK£0.071 | 3.6% +UK£1.7m | -33.5% | PS1x | |
| DXRX Diaceutics | UK£1.46 | 0.7% +UK£846.7k | 25.3% | PE1274.4x | |
| FAB Fusion Antibodies | UK£0.12 | 4.3% +UK£625.1k | 86.0% | PS9.4x |